Metabolism of the glutamic acid in the central nervous system. II. Factors which influence the intensity of the reduction of the NBT in sections of the spinal cord.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000818:Animals; D002415:Cats; D002952:Citric Acid Cycle; D005969:Glutamate Dehydrogenase / Q000037:antagonists & inhibitors*; D005971:Glutamates / Q000378:metabolism*; D006150:Guanine Nucleotides / Q000494:pharmacology; D010084:Oxidation-Reduction; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013116:Spinal Cord / Q000166:cytology / Q000378:metabolism*; D013778:Tetrazolium Salts / Q000378:metabolism*
D000227:Adenine Nucleotides; D005971:Glutamates; D006150:Guanine Nucleotides; D000644:Quaternary Ammonium Compounds; D013778:Tetrazolium Salts; D011732:Pyridoxal Phosphate; D005969:Glutamate Dehydrogenase